• Tidak ada hasil yang ditemukan

DAFTAR PUSTAKA. mechanisms, predisposition, and treatment. Journal of Pregnancy[Internet].

N/A
N/A
Protected

Academic year: 2021

Membagikan "DAFTAR PUSTAKA. mechanisms, predisposition, and treatment. Journal of Pregnancy[Internet]."

Copied!
40
0
0

Teks penuh

(1)

65

1.

Vitoratos N, Vrachnis N, Iavazzo C, Kyorgiou M. Preeclampsia: molecular

mechanisms, predisposition, and treatment. Journal of Pregnancy[Internet].

2012

[cited

2014

Nov

18].

Available

from

:

http://dx.doi.org/10.1155/2012/145487.

2.

Guerrier G, Oluyide B, Keramarou M, Grais RF. Factors associated with

severe preeclampsiaand eclampsia in Jahun, Nigeria. International Journal of

Women’s Health. 2013; 5; 509-513.

3.

Cunningham FG, Levenno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY.

Hipertensi dalam kehamilan. In : Pendit BU, Setia R, editor. Obstetri

williams. 23

th

ed. Jakarta : Penerbit Buku Kedokteran EGC; 2013 : 740-794.

4.

Backes CH, Markham K, Moorehead P, Cordero L, Nankervis CA, Giannone

PJ. Maternal preeclampsia and neonatal outcomes. Journal of Pregnancy

[Internet].

2011

[cited

2014

Nov

25].

Available

from

:

http://dx.doi.org/10.1155/2011/214365.

5.

Membedah angka kematian ibu : penyebab dan akar masalah tingginya angka

kematian ibu. Konferensi INFID; 2013 November 26-27. Jakarta; 2014.

6.

Widiyanto. Kehamilan dengan preeklampsia berat [thesis]. Semarang: Bagian

Obstestri dan Ginekologi Fakultas Kedokteran Universitas Diponegoro; 2005.

7.

Manuaba IBG, Manuaba IAC, Manuaba IBGF. Hipertensi dalam kehamilan.

In : Astuti NZ, Purba DI, Handayani S, Damayanti R, editor. Pengantar

kuliah obstetri. Jakarta : Penerbit Buku Kedokteran EGC; 2003.

(2)

8.

DeCherney AH, Nathan L. Hypertensive states of pregnancy. In : Current

obstetric and gynecologic diagnosis and treatment. 9

th

ed. New York :

McGRAW-HILL Inc; 2003.

9.

Canzoneri BJ, Lewis DF, Groome L, Wang Y. Increased neutrophil number

account for leukocytosis in women with preeclampsia. American Journal of

Perinatology. 2011.

10.

Gana YY. Hubungan kadar hematokrit dengan derajat preeklampsia.

Surakarta : Fakultas Kedokteran Universitas Sebelas Maret; 2010.

11.

Yusrianty D, Lukas E, Tahir M. Kadar serum P38 MAPK, profil darah pada

pasien preeklampsia berat dibandingkan kehamilan normal. JST Kesehatan.

2014; 4(3): 291-298.

12.

Adhie RP. Hubungan antara kadar hematokrit dan trombosit maternal

terhadap keluaran perinatal pada eklampsia berat [thesis]. Semarang : Bagian

Obstetri dan Ginekologi Fakultas Kedokteran Universitas Diponegoro; 2004.

13.

Kawuryan SL. Pengaruh kadar trombosit, hematokrit, hemoglobin darah dan

protein urin pada ibu preeklampsia/eklampsia terhadap nilai apgar bayi yang

dilahirkan. Jurnal Kedokteran Brawijaya. 2004; 20(2): 78-81.

14.

Poon LC, Nicolaides KH. Early prediction of preeclampsia. Obstetrics and

Gynecology International[Internet]. 2014 [cited 2014 Nov 17]. Available

from : http://dx.doi.org/10.1155/2014/297397

15.

Moura SAMH, Lopes LM, Murthi P, Costa FS. Prevention of preeclampsia.

Journal of Pregnancy[Internet]. 2012 [cited 2014 Nov 17]. Available from :

http://dx.doi.org/10.1155/2012/435090.

(3)

16.

Angsar MD. Hipertensi dalam kehamilan. In : Saifuddin AB, Rachimhadhi T,

Wiknjosastro GH, editor. Ilmu kebidanan sarwono prawirohardjo. Edisi

keempat. Jakarta : Bina Pustaka Sarwono Prawirohadjo; 2011.

17.

Birawa AD, Hadisaputro H, Hadijono S. Kadar d-dimer pada ibu hamil

dengan preeklampsia berat dan normotensi di rsup dr. kariadi. Majalah

Obstetri Ginekologi Indonesia. 2009; 33(2): 65-78.

18.

Diagnosis and management of preeclampsia and eclampsia. ACOC Practice

Bulletin: Clinical Management Guideline for Obstetrician-Gynecologists.

2002; 33.

19.

Vanderlelie J. Placental oxidative stress in preeclampsia[thesis]. Brisbane:

Griffith University; 2005.

20.

Powe CE, Levine RJ, Karumanchi A. Preeclampsia, a disease of the maternal

endothelium : the role of antiangiogenic factors and implications for later

cardiovascular disease. American Heart Association Journals. 2014.

21.

Indrianto A, Hadisaputro H. Preeklampsia berat di RS Dr. Kariadi periode 1

januari 2004 – 31 desember 2004[thesis]. Semarang: Bagian Obstestri dan

Ginekologi Fakultas Kedokteran Universitas Diponegoro; 2009.

22.

Nugroho T. Patologi kebidanan. Yogyakarta: Nuha Medika; 2012: 1-12.

23.

Nankali A, Malek-khosravi S, Zangeneh M, Rezaei M, Hemati Z, Kohzadi

M. Maternal complication associated with severe preeclampsia. The Journal

of Obstetrics and Gynecology of India. 2013; 63(2) : 112-115.

(4)

24.

Eiland E, Nzerue C, Faulkner M. Preeclampsia 2012. Journal of

Pregnancy[internet].

2012[cited

2015

Jan

19].

Availabel

from:

http://dx.doi.org/10.1155/2012/586578.

25.

Sacher RA, McPherson RA. Widmann’s clinical interpretation of laboratory

test. In : Brahm U, Wulandari D, Hartanto H. Tinjauan klinis hasil

pemeriksaan laboratorium. 11

th

ed. Jakarta : Penerbit Buku Kedokteran EGC;

2004 : 21-66.

26.

Tarwoto, Watonah. Keperawatan medikal bedah: gangguan sistem

hematologi. Jakarta : Trans Info Media; 2008: 9-29.

27.

Gandasoebrata R. Penuntun laboratorium klinik. Jakarta : Dian Rakyat; 2007:

11-14.

28.

Sutedjo AY. Buku saku mengenal penyakit melalui hasil pemeriksaan

laboratorium. Yogyakarta : Penerbit Amara Books; 2009: 17-35.

29.

EffendiZ. Peranan leukosit sebagai anti inflamasi alergik dalam

tubuh[internet].

2003[cited

2015

Jan

31].

Availabel

from:

library.usu.ac.id/download/fk/histologi-zukesti2.pdf.

30.

Mudita IB. Sel darah putih: gangguan fungsi granulosit dan granulopoiesis. In

: Permono HB, Sutaryo, Ugrasena IGD, Windiastuti E, Abdulsalam M. Buku

ajar hematologi-onkologi anak. Jakarta : Badan Penerbit IDAI, 2012:

101-132.

31.

Kee JL. Laboratory and diagnostic tests with nursing implication. In :

Kurnianingsih S, Widyastuti P, Cahyaningrum R, Rahayu S. Pedoman

(5)

pemeriksaan laboratorium dan diagnostik. 6

th

ed. Jakarta: Penerbit Buku

Kedokteran EGC; 2003: 479-482.

32.

Onisai M, Vladareanu A, Bumbea H, Ciorascu M, Pop C, Andrei C, et al. A

study of hematologycal picture and of platelet function in preeclampsia.

Maedica : A Journal of Clinical Medicine. 2009; 4(4): 327-337.

33.

Sabatier F, Bretelle F, d’Ercole C, Boubli L, Sampol J, Dignat-George F.

Neutrophil activation in preeclampsia and isolated intrauterine growth

restriction. American Journals of Obstetric and Gynecology. 2000; 183(6) :

1558-1563.

34.

Mihu D, Sabau L, Costin N, Ciortea R, Oancea M, Malutan A. Evaluation of

leukocytes and neutrophils, markers of inflammatory syndrome in

preeclampsia. Applied Medical Informatics. 2010; 27(3) : 15-22.

35.

Raras AA. Pengaruh preeklampsia berat pada kehamilan terhadap keluaran

maternal dan perinatal di RSUP Dr. Kariadi tahun 2010. Semarang : Fakultas

Kedokteran Universitas Diponegoro; 2011.

36.

Konimusliha P. Hubungan antara frekuensi pelayanan antenatal dengan

kejadian preeklampsia berat : studi kasus di RSUP Dr. Kariadi tahun 2010.

Semarang : Fakultas Kedokteran Universitas Diponegoro; 2011.

37.

Kuriakose P. Anemia: an approach to evaluation, 2014. CHRISMED Journal

of Health and Research [internet]. 2015; 2(2) : 95-99 [cited 17 Jun 2015].

Availabel

from

:

http://www.cjhr.org/article.asp?issn=2348-3334;year=2015;volume=2;issue=2;spage=95;epage=99;aulast=Kuriakose

(6)

38.

Monteiro G, Subbalakshmi, Pai SR. Revelance of measurement of

hematological parameters in subjects with pregnancy induced hypertention.

Nitte University Journal of Health Science. 2014; 4(1) : 15-20.

39.

Yang SW, Cho SH, Kwon HS, Sohn IS, Hwang HS. Significance of the

platelet distribution width as a severity marker for the development of

preeclampsia. European Journal of Obstetrics & Gynecology and

Reproductive Biology. 2014; 175 : 107-111.

40.

Selamat, Aditiawarman. Clinical and laboratory profiles relationships of

preeclampsia-eclampsia patients with maternal mortality in Dr. Soetomo

hospital, Surabaya. Majalah Obstetri & Ginekologi. 2012; 20 (1) : 35-39.

41.

Jwa SC, Fujiwara T, Yamanobe Y, Kozuka K, Sago H.Changes in maternal

hemoglobin during pregnancy and birth outcomes. BMC Pregnancy and

Childbirth. 2015; 15 : 80.

(7)
(8)
(9)

Lampiran 3. Hasil

Output SPSS

Deskripsi Usia Pasien Preeklampsia

Statistic Std. Error

Usia

Mean 29,05 ,770

95% Confidence Interval for Mean Lower Bound 27,52 Upper Bound 30,58 5% Trimmed Mean 28,91 Median 28,00 Variance 50,379 Std. Deviation 7,098 Minimum 16 Maximum 48 Range 32 Interquartile Range 12 Skewness ,253 ,261 Kurtosis -,718 ,517

Deskripsi Usia Kelompok Kontrol

Statistic Std. Error

Usia

Mean 27,88 ,658

95% Confidence Interval for Mean Lower Bound 26,57 Upper Bound 29,19 5% Trimmed Mean 27,78 Median 28,00 Variance 36,819 Std. Deviation 6,068 Minimum 15 Maximum 47 Range 32 Interquartile Range 8 Skewness ,251 ,261 Kurtosis ,110 ,517

(10)

Frekuensi Usia Preeklampsia Ringan

Frequency Percent Valid Percent Cumulative Percent

Valid

<20 tahun 1 7,7 7,7 7,7

20-35 tahun 9 69,2 69,2 76,9

>35 tahun 3 23,1 23,1 100,0

Total 13 100,0 100,0

Frekuensi Usia Preeklampsia Berat

Frequency Percent Valid Percent Cumulative Percent

Valid

<20 tahun 4 7,1 7,1 7,1

20-35 tahun 37 66,1 66,1 73,2 >35 tahun 15 26,8 26,8 100,0

Total 56 100,0 100,0

Frekuensi Usia Eklampsia

Frequency Percent Valid Percent Cumulative Percent

Valid

<20 tahun 2 12,5 12,5 12,5 20-35 tahun 12 75,0 75,0 87,5 >35 tahun 2 12,5 12,5 100,0

Total 16 100,0 100,0

Frekuensi Usia Kelompok Kontrol

Frequency Percent Valid Percent Cumulative Percent Valid <20 tahun 9 10,6 10,6 10,6 20-35 tahun 10 11,8 11,8 22,4 >35 tahun 66 77,6 77,6 100,0 Total 85 100,0 100,0

Frekuensi Alamat Preeklampsia Ringan

Frequency Percent Valid Percent Cumulative Percent

Valid

Semarang 12 92,3 92,3 92,3

Luar Semarang 1 7,7 7,7 100,0

Total 13 100,0 100,0

Frekuensi Alamat Preeklampsia Berat

Frequency Percent Valid Percent Cumulative Percent

Valid

Semarang 33 58,9 58,9 58,9

Luar Semarang 23 41,1 41,1 100,0

(11)

Frekuensi Alamat Eklampsia

Frequency Percent Valid Percent Cumulative Percent

Valid

Semarang 4 25,0 25,0 25,0

Luar Semarang 12 75,0 75,0 100,0

Total 16 100,0 100,0

Frekuensi Alamat Kelompok Kontrol

Frequency Percent Valid Percent Cumulative Percent

Valid

Semarang 68 80,0 80,0 80,0

Luar Semarang 17 20,0 20,0 100,0

Total 85 100,0 100,0

Frekuensi Tingkat Pendidikan Preeklampsia Ringan

Frequency Percent Valid Percent Cumulative Percent

Valid

Dasar 4 30,8 30,8 30,8

Menengah 9 69,2 69,2 100,0

Total 13 100,0 100,0

FrekuensiTingkat Pendidikan Preeklampsia Berat

Frequency Percent Valid Percent Cumulative Percent Valid Tidak Sekolah 3 5,4 5,4 5,4 Dasar 22 39,3 39,3 44,6 Menengah 26 46,4 46,4 91,1 Tinggi 5 8,9 8,9 100,0 Total 56 100,0 100,0

FrekuensiTingkat Pendidikan Eklampsia

Frequency Percent Valid Percent Cumulative Percent Valid Tidak Sekolah 2 12,5 12,5 12,5 Dasar 5 31,3 31,3 43,8 Menengah 9 56,3 56,3 100,0 Total 16 100,0 100,0

(12)

FrekuensiTingkat Pendidikan Kelompok Kontrol

Frequency Percent Valid Percent Cumulative Percent Valid Dasar 17 20,0 20,0 20,0 Menengah 43 50,6 50,6 70,6 Tinggi 25 29,4 29,4 100,0 Total 85 100,0 100,0

FrekuensiStatus Pekerjaan Preeklampsia Ringan

Frequency Percent Valid Percent Cumulative Percent

Valid

Bekerja 1 7,7 7,7 7,7

Tidak Bekerja 12 92,3 92,3 100,0

Total 13 100,0 100,0

FrekuensiStatus Pekerjaan Preeklampsia Berat

Frequency Percent Valid Percent Cumulative Percent

Valid

Bekerja 13 23,2 23,2 23,2

Tidak Bekerja 43 76,8 76,8 100,0

Total 56 100,0 100,0

FrekuensiStatus Pekerjaan Eklampsia

Frequency Percent Valid Percent Cumulative Percent

Valid

Bekerja 2 12,5 12,5 12,5

Tidak Bekerja 14 87,5 87,5 100,0

Total 16 100,0 100,0

FrekuensiStatus Pekerjaan Kelompok Kontrol

Frequency Percent Valid Percent Cumulative Percent

Valid

Bekerja 23 27,1 27,1 27,1

Tidak Bekerja 62 72,9 72,9 100,0

Total 85 100,0 100,0

FrekuensiGravida Preeklampsia Ringan

Frequency Percent Valid Percent Cumulative Percent

Valid

Primigravida 6 46,2 46,2 46,2 Multigravida 7 53,8 53,8 100,0

(13)

FrekuensiGravida Preeklampsia Berat

Frequency Percent Valid Percent Cumulative Percent Valid Primigravida 12 21,4 21,4 21,4 Multigravida 41 73,2 73,2 94,6 Grande Multigravida 3 5,4 5,4 100,0 Total 56 100,0 100,0 FrekuensiGravida Eklampsia

Frequency Percent Valid Percent Cumulative Percent Valid Primigravida 11 68,8 68,8 68,8 Multigravida 4 25,0 25,0 93,8 Grande Multigravida 1 6,3 6,3 100,0 Total 16 100,0 100,0

FrekuensiGravida Kelompok Kontrol

Frequency Percent Valid Percent Cumulative Percent Valid Primigravida 29 34,1 34,1 34,1 Multigravida 50 58,8 58,8 92,9 Grande Multigravida 6 7,1 7,1 100,0 Total 85 100,0 100,0

Frekuensi Jumlah Paritas Preeklampsia Ringan

Frequency Percent Valid Percent Cumulative Percent Valid Nulipara 7 53,8 53,8 53,8 Primipara 2 15,4 15,4 69,2 Multipara 4 30,8 30,8 100,0 Total 13 100,0 100,0

Frekuensi Jumlah ParitasPreeklampsia Berat

Frequency Percent Valid Percent Cumulative Percent Valid Nulipara 15 26,8 26,8 26,8 Primipara 19 33,9 33,9 60,7 Multipara 22 39,3 39,3 100,0 Total 56 100,0 100,0

(14)

Frekuensi Jumlah Paritas Eklampsia

Frequency Percent Valid Percent Cumulative Percent Valid Nullipara 12 75,0 75,0 75,0 Primipara 1 6,3 6,3 81,3 Multipara 3 18,8 18,8 100,0 Total 16 100,0 100,0

Frekuensi Jumlah Paritas Kelompok Kontrol

Frequency Percent Valid Percent Cumulative Percent Valid Nullipara 34 40,0 40,0 40,0 Primipara 28 32,9 32,9 72,9 Multipara 21 24,7 24,7 97,6 Grande Multipara 2 2,4 2,4 100,0 Total 85 100,0 100,0

Deskripsi Usia Kehamilan Preeklampsia

Statistic Std. Error

Usia Kehamilan

Mean 36,25 ,338

95% Confidence Interval for Mean Lower Bound 35,57 Upper Bound 36,92 5% Trimmed Mean 36,39 Median 37,00 Variance 9,712 Std. Deviation 3,116 Minimum 28 Maximum 42 Range 14 Interquartile Range 4 Skewness -,702 ,261 Kurtosis -,117 ,517

(15)

Deskripsi Usia Kehamilan Kelompok Kontrol

Statistic Std. Error

Usia Kehamilan

Mean 38,27 ,259

95% Confidence Interval for Mean Lower Bound 37,76 Upper Bound 38,79 5% Trimmed Mean 38,50 Median 39,00 Variance 5,700 Std. Deviation 2,387 Minimum 27 Maximum 42 Range 15 Interquartile Range 3 Skewness -1,931 ,261 Kurtosis 5,917 ,517

Frekuensi Usia Kehamilan Preeklampsia Ringan

Frequency Percent Valid Percent Cumulative Percent

Valid

Prematur 2 15,4 15,4 15,4

Aterm 11 84,6 84,6 100,0

Total 13 100,0 100,0

FrekuensiUsia Kehamilan Preeklampsia Berat

Frequency Percent Valid Percent Cumulative Percent Valid Prematur 24 42,9 42,9 42,9 Aterm 30 53,6 53,6 96,4 Serotinus 2 3,6 3,6 100,0 Total 56 100,0 100,0

FrekuensiUsia Kehamilan Eklampsia

Frequency Percent Valid Percent Cumulative Percent Valid Prematur 9 56,3 56,3 56,3 Aterm 6 37,5 37,5 93,8 Serotinus 1 6,3 6,3 100,0 Total 16 100,0 100,0

(16)

FrekuensiUsia Kehamilan Kelompok Kontrol

Frequency Percent Valid Percent Cumulative Percent Valid Prematur 10 11,8 11,8 11,8 Aterm 65 76,5 76,5 88,2 Serotinus 10 11,8 11,8 100,0 Total 85 100,0 100,0

Frekuensi ANC Preeklampsia Ringan

Frequency Percent Valid Percent Cumulative Percent

Valid

<4 3 23,1 23,1 23,1

≥4 10 76,9 76,9 100,0

Total 13 100,0 100,0

FrekuensiANC Preeklampsia Berat

Frequency Percent Valid Percent Cumulative Percent

Valid

<4 9 16,1 16,1 16,1

≥4 47 83,9 83,9 100,0

Total 56 100,0 100,0

Frekuensi ANC Eklampsia

Frequency Percent Valid Percent Cumulative Percent

Valid

<4 4 25,0 25,0 25,0

≥4 12 75,0 75,0 100,0

Total 16 100,0 100,0

Frekuensi ANC Kelompok Kontrol

Frequency Percent Valid Percent Cumulative Percent

Valid

<4 13 15,3 15,3 15,3

≥4 72 84,7 84,7 100,0

Total 85 100,0 100,0

FrekuensiRujukan Preeklampsia Ringan

Frequency Percent Valid Percent Cumulative Percent Valid Datang Sendiri 8 61,5 61,5 61,5 Bidan 2 15,4 15,4 76,9 Dokter Umum 1 7,7 7,7 84,6 RS Pemerintah 1 7,7 7,7 92,3 RS Swasta 1 7,7 7,7 100,0 Total 13 100,0 100,0

(17)

FrekuensiRujukan Preeklampsia Berat

Frequency Percent Valid Percent Cumulative Percent Valid Datang Sendiri 31 55,4 55,4 55,4 Bidan 8 14,3 14,3 69,6 Dokter Umum 3 5,4 5,4 75,0 RS Pemerintah 9 16,1 16,1 91,1 RS Swasta 5 8,9 8,9 100,0 Total 56 100,0 100,0 FrekuensiRujukan Eklampsia

Frequency Percent Valid Percent Cumulative Percent Valid Datang Sendiri 12 75,0 75,0 75,0 RS Pemerintah 2 12,5 12,5 87,5 RS Swasta 2 12,5 12,5 100,0 Total 16 100,0 100,0

Frekuensi Rujukan Kelompok Kontrol

Frequency Percent Valid Percent Cumulative Percent Valid Datang Sendiri 65 76,5 76,5 76,5 Bidan 8 9,4 9,4 85,9 Dokter Umum 3 3,5 3,5 89,4 Dokter Spesialis 2 2,4 2,4 91,8 RS Pemerintah 4 4,7 4,7 96,5 Puskesmas 2 2,4 2,4 98,8 BP/Poliklinik 1 1,2 1,2 100,0 Total 85 100,0 100,0

FrekuensiJenis Partus Preeklampsia Ringan

Frequency Percent Valid Percent Cumulative Percent Valid Bedah Sesar 2 15,4 15,4 15,4 Spontan Pervaginam 7 53,8 53,8 69,2 Vakum Pervaginam 4 30,8 30,8 100,0 Total 13 100,0 100,0

(18)

FrekuensiJenis Partus Preeklampsia Berat

Frequency Percent Valid Percent Cumulative Percent Valid Bedah Sesar 27 48,2 48,2 48,2 Spontan Pervaginam 23 41,1 41,1 89,3 Vakum Pervaginam 6 10,7 10,7 100,0 Total 56 100,0 100,0

FrekuensiJenis Partus Eklampsia

Frequency Percent Valid Percent Cumulative Percent

Valid

Bedah Sesar 13 81,3 81,3 81,3

Spontan Pervaginam 3 18,8 18,8 100,0

Total 16 100,0 100,0

FrekuensiJenis Partus Kelompok Kontrol

Frequency Percent Valid Percent Cumulative Percent Valid Spontan Pervaginam 85 100,0 100,0 100,0

Frekuensi BMI Preeklampsia Ringan

Frequency Percent Valid Percent Cumulative Percent

Valid

≥25 1 7,7 7,7 7,7

<25 12 92,3 92,3 100,0

Total 13 100,0 100,0

Frekuensi BMI Preeklampsia Berat

Frequency Percent Valid Percent Cumulative Percent

Valid

≥25 20 35,7 35,7 35,7

<25 36 64,3 64,3 100,0

Total 56 100,0 100,0

Frekuensi BMI Eklampsia

Frequency Percent Valid Percent Cumulative Percent Valid <25 16 100,0 100,0 100,0

(19)

Frekuensi BMI Kelompok Kontrol

Frequency Percent Valid Percent Cumulative Percent

Valid

≥25 2 2,4 2,4 2,4

<25 83 97,6 97,6 100,0

Total 85 100,0 100,0

Frekuensi Anemia Preeklampsia Ringan

Frequency Percent Valid Percent Cumulative Percent Valid Anemia Mikrositik Hipokromik 2 15,4 15,4 15,4 Anemia Normositik Normokromik 1 7,7 7,7 23,1 Tidak Anemia 10 76,9 76,9 100,0 Total 13 100,0 100,0

Frekuensi Anemia Preeklampsia Berat

Frequency Percent Valid Percent Cumulative Percent Valid Anemia Mikrositik Hipokromik 3 5,4 5,4 5,4 Tidak Anemia 53 94,6 94,6 100,0 Total 56 100,0 100,0 Anemia

Frequency Percent Valid Percent Cumulative Percent Valid Anemia Mikrositik Hipokromik 1 6,3 6,3 6,3 Tidak Anemia 15 93,8 93,8 100,0 Total 16 100,0 100,0

Frekuensi Anemia Kelompok Kontrol

Frequency Percent Valid Percent Cumulative Percent Valid Anemia Mikrositik Hipokromik 9 10,6 10,6 10,6 Anemia Normositik Normokromik 1 1,2 1,2 11,8 Tidak Anemia 75 88,2 88,2 100,0 Total 85 100,0 100,0

(20)

Frekuensi Sindroma HELLP Preeklampsi Ringan

Frequency Percent Valid Percent Cumulative Percent Valid Tidak Sindroma HELLP 13 100,0 100,0 100,0

Frekuensi Sindroma HELLP Preeklampsia Berat

Frequency Percent Valid Percent Cumulative Percent

Valid

Sindroma HELLP 6 10,7 10,7 10,7

Tidak Sindroma HELLP 50 89,3 89,3 100,0

Total 56 100,0 100,0

Frekuensi Sindroma HELLP Eklampsia

Frequency Percent Valid Percent Cumulative Percent

Valid

Sindroma HELLP 1 6,3 6,3 6,3

Tidak Sindroma HELLP 15 93,8 93,8 100,0

Total 16 100,0 100,0

Frekuensi Sindroma HELLP Kelompok Kontrol

Frequency Percent Valid Percent Cumulative Percent Valid Tidak Sindroma HELLP 85 100,0 100,0 100,0

Kejang pada Eklampsia

Frequency Percent Valid Percent Cumulative Percent Valid Kejang 16 100,0 100,0 100,0

Deskripsi Profil Hematologi

Jenis_perlakuan Statistic Std. Error

Eritrosit Eklampsia

Mean 4,3563 ,19205

95% Confidence Interval for Mean Lower Bound 3,9469 Upper Bound 4,7656 5% Trimmed Mean 4,4058 Median 4,4500 Variance ,590 Std. Deviation ,76821 Minimum 2,20 Maximum 5,62 Range 3,42 Interquartile Range ,61 Skewness -1,386 ,564 Kurtosis 3,644 1,091

(21)

Eritrosit

PE Berat

Mean 4,4535 ,06709

95% Confidence Interval for Mean Lower Bound 4,3191 Upper Bound 4,5880 5% Trimmed Mean 4,4484 Median 4,5000 Variance ,252 Std. Deviation ,50209 Minimum 3,30 Maximum 5,60 Range 2,30 Interquartile Range ,54 Skewness ,295 ,319 Kurtosis ,147 ,628 PE Ringan Mean 3,8655 ,14695

95% Confidence Interval for Mean Lower Bound 3,5453 Upper Bound 4,1856 5% Trimmed Mean 3,8838 Median 3,8000 Variance ,281 Std. Deviation ,52983 Minimum 2,60 Maximum 4,80 Range 2,20 Interquartile Range ,50 Skewness -,713 ,616 Kurtosis 2,177 1,191 Kontrol Mean 4,0863 ,04989

95% Confidence Interval for Mean Lower Bound 3,9871 Upper Bound 4,1855 5% Trimmed Mean 4,0899 Median 4,1000 Variance ,212 Std. Deviation ,46000 Minimum 2,10 Maximum 5,20 Range 3,10 Interquartile Range ,55 Skewness -,639 ,261 Kurtosis 3,286 ,517

(22)

Hemoglobin

Eklampsia

Mean 12,3500 ,49007

95% Confidence Interval for Mean Lower Bound 11,3054 Upper Bound 13,3946 5% Trimmed Mean 12,5778 Median 12,8500 Variance 3,843 Std. Deviation 1,96027 Minimum 6,30 Maximum 14,30 Range 8,00 Interquartile Range 1,58 Skewness -2,250 ,564 Kurtosis 5,870 1,091 PE Berat Mean 12,4609 ,22712

95% Confidence Interval for Mean Lower Bound 12,0057 Upper Bound 12,9161 5% Trimmed Mean 12,4581 Median 12,6500 Variance 2,889 Std. Deviation 1,69961 Minimum 8,50 Maximum 16,90 Range 8,40 Interquartile Range 1,95 Skewness ,023 ,319 Kurtosis ,327 ,628 PE Ringan Mean 10,8062 ,47592

95% Confidence Interval for Mean Lower Bound 9,7692 Upper Bound 11,8431 5% Trimmed Mean 10,8179 Median 10,8000 Variance 2,944 Std. Deviation 1,71595 Minimum 7,80 Maximum 13,60 Range 5,80 Interquartile Range 2,84 Skewness ,030 ,616 Kurtosis -,666 1,191

(23)

Kontrol

Mean 11,5136 ,17949

95% Confidence Interval for Mean Lower Bound 11,1567 Upper Bound 11,8706 5% Trimmed Mean 11,5881 Median 11,7200 Variance 2,738 Std. Deviation 1,65482 Minimum 7,10 Maximum 14,60 Range 7,50 Interquartile Range 2,00 Skewness -,766 ,261 Kurtosis ,320 ,517 Hematokrit Eklampsia Mean 36,2188 1,41728

95% Confidence Interval for Mean Lower Bound 33,1979 Upper Bound 39,2396 5% Trimmed Mean 36,9153 Median 38,5500 Variance 32,139 Std. Deviation 5,66912 Minimum 18,60 Maximum 41,30 Range 22,70 Interquartile Range 3,95 Skewness -2,341 ,564 Kurtosis 6,115 1,091 PE Berat Mean 36,5673 ,61608

95% Confidence Interval for Mean Lower Bound 35,3327 Upper Bound 37,8020 5% Trimmed Mean 36,5292 Median 36,9350 Variance 21,255 Std. Deviation 4,61031 Minimum 25,90 Maximum 48,00 Range 22,10 Interquartile Range 5,50 Skewness ,162 ,319 Kurtosis ,408 ,628

Hemoglobin

(24)

Hematokrit

PE Ringan

Mean 31,9623 1,24425

95% Confidence Interval for Mean Lower Bound 29,2513 Upper Bound 34,6733 5% Trimmed Mean 32,0637 Median 33,4000 Variance 20,126 Std. Deviation 4,48622 Minimum 23,80 Maximum 38,30 Range 14,50 Interquartile Range 7,50 Skewness -,326 ,616 Kurtosis -,928 1,191 Kontrol Mean 33,5013 ,48095

95% Confidence Interval for Mean Lower Bound 32,5449 Upper Bound 34,4577 5% Trimmed Mean 33,6486 Median 34,2000 Variance 19,662 Std. Deviation 4,43418 Minimum 22,10 Maximum 42,80 Range 20,70 Interquartile Range 6,05 Skewness -,604 ,261 Kurtosis ,190 ,517 MCH Eklampsia Mean 28,1125 ,74184

95% Confidence Interval for Mean Lower Bound 26,5313 Upper Bound 29,6937 5% Trimmed Mean 28,0972 Median 28,7000 Variance 8,805 Std. Deviation 2,96735 Minimum 23,00 Maximum 33,50 Range 10,50 Interquartile Range 4,20 Skewness -,210 ,564 Kurtosis -,215 1,091

(25)

PE Berat

Mean 28,1013 ,38351

95% Confidence Interval for Mean Lower Bound 27,3327 Upper Bound 28,8698 5% Trimmed Mean 28,3188 Median 28,7000 Variance 8,236 Std. Deviation 2,86992 Minimum 18,80 Maximum 32,68 Range 13,88 Interquartile Range 3,61 Skewness -1,248 ,319 Kurtosis 1,858 ,628 PE Ringan Mean 28,2331 ,78008

95% Confidence Interval for Mean Lower Bound 26,5334 Upper Bound 29,9327 5% Trimmed Mean 28,3534 Median 28,5000 Variance 7,911 Std. Deviation 2,81263 Minimum 22,40 Maximum 31,90 Range 9,50 Interquartile Range 3,92 Skewness -,789 ,616 Kurtosis ,114 1,191 Kontrol Mean 28,2878 ,41249

95% Confidence Interval for Mean Lower Bound 27,4675 Upper Bound 29,1080 5% Trimmed Mean 28,3838 Median 29,0000 Variance 14,462 Std. Deviation 3,80294 Minimum 18,70 Maximum 40,90 Range 22,20 Interquartile Range 4,59 Skewness -,412 ,261 Kurtosis 1,174 ,517

MCH

(26)

MCV

Eklampsia

Mean 82,9125 1,74052

95% Confidence Interval for Mean Lower Bound 79,2027 Upper Bound 86,6223 5% Trimmed Mean 83,1972 Median 83,6500 Variance 48,471 Std. Deviation 6,96208 Minimum 68,80 Maximum 91,90 Range 23,10 Interquartile Range 8,50 Skewness -,871 ,564 Kurtosis ,014 1,091 PE Berat Mean 82,2202 ,91094

95% Confidence Interval for Mean Lower Bound 80,3946 Upper Bound 84,0457 5% Trimmed Mean 82,7823 Median 83,2500 Variance 46,470 Std. Deviation 6,81687 Minimum 58,80 Maximum 93,20 Range 34,40 Interquartile Range 6,50 Skewness -1,460 ,319 Kurtosis 2,829 ,628 PE Ringan Mean 83,7623 2,36788

95% Confidence Interval for Mean Lower Bound 78,6031 Upper Bound 88,9215 5% Trimmed Mean 84,0915 Median 88,5000 Variance 72,889 Std. Deviation 8,53750 Minimum 67,60 Maximum 94,00 Range 26,40 Interquartile Range 13,01 Skewness -,684 ,616 Kurtosis -,724 1,191

(27)

MCV Kontrol

Mean 82,2678 1,04077

95% Confidence Interval for Mean Lower Bound 80,1981 Upper Bound 84,3375 5% Trimmed Mean 82,4511 Median 84,3000 Variance 92,072 Std. Deviation 9,59544 Minimum 58,70 Maximum 118,20 Range 59,50 Interquartile Range 8,70 Skewness -,217 ,261 Kurtosis 1,981 ,517 MCHC Eklampsia Mean 33,8563 ,37081

95% Confidence Interval for Mean Lower Bound 33,0659 Upper Bound 34,6466 5% Trimmed Mean 33,8903 Median 33,7000 Variance 2,200 Std. Deviation 1,48323 Minimum 30,60 Maximum 36,50 Range 5,90 Interquartile Range 1,13 Skewness ,047 ,564 Kurtosis ,974 1,091 PE Berat Mean 34,0146 ,18532

95% Confidence Interval for Mean Lower Bound 33,6433 Upper Bound 34,3860 5% Trimmed Mean 34,0544 Median 34,1000 Variance 1,923 Std. Deviation 1,38680 Minimum 30,30 Maximum 36,50 Range 6,20 Interquartile Range 2,10 Skewness -,524 ,319 Kurtosis -,334 ,628

(28)

PE Ringan

Mean 33,7600 ,43200

95% Confidence Interval for Mean Lower Bound 32,8187 Upper Bound 34,7013 5% Trimmed Mean 33,8833 Median 33,9000 Variance 2,426 Std. Deviation 1,55760 Minimum 29,70 Maximum 35,60 Range 5,90 Interquartile Range 1,95 Skewness -1,385 ,616 Kurtosis 3,163 1,191 Kontrol Mean 34,3093 ,12284

95% Confidence Interval for Mean Lower Bound 34,0650 Upper Bound 34,5536 5% Trimmed Mean 34,3361 Median 34,3000 Variance 1,283 Std. Deviation 1,13255 Minimum 31,30 Maximum 36,60 Range 5,30 Interquartile Range 1,45 Skewness -,333 ,261 Kurtosis -,078 ,517 Leukosit Eklampsia Mean 20,3756 1,81807

95% Confidence Interval for Mean Lower Bound 16,5005 Upper Bound 24,2507 5% Trimmed Mean 20,3063 Median 20,0500 Variance 52,886 Std. Deviation 7,27227 Minimum 10,20 Maximum 31,80 Range 21,60 Interquartile Range 14,63 Skewness ,239 ,564 Kurtosis -1,272 1,091

MCHC

(29)

PE Berat

Mean 14,5888 ,50729

95% Confidence Interval for Mean Lower Bound 13,5721 Upper Bound 15,6054 5% Trimmed Mean 14,4857 Median 13,4500 Variance 14,411 Std. Deviation 3,79621 Minimum 6,23 Maximum 25,90 Range 19,67 Interquartile Range 5,00 Skewness ,598 ,319 Kurtosis ,394 ,628 PE Ringan Mean 13,4500 1,03077

95% Confidence Interval for Mean Lower Bound 11,2042 Upper Bound 15,6958 5% Trimmed Mean 13,3028 Median 13,4000 Variance 13,812 Std. Deviation 3,71649 Minimum 8,84 Maximum 20,71 Range 11,87 Interquartile Range 4,40 Skewness ,847 ,616 Kurtosis ,200 1,191 Kontrol Mean 12,4215 ,34491

95% Confidence Interval for Mean Lower Bound 11,7356 Upper Bound 13,1074 5% Trimmed Mean 12,3151 Median 12,3000 Variance 10,112 Std. Deviation 3,17991 Minimum 6,60 Maximum 23,20 Range 16,60 Interquartile Range 4,52 Skewness ,443 ,261 Kurtosis ,403 ,517

Leukosit

(30)

Trombosit

Eklampsia

Mean 247,3313 26,89517

95% Confidence Interval for Mean Lower Bound 190,0056 Upper Bound 304,6569 5% Trimmed Mean 248,6236 Median 256,5000 Variance 11573,602 Std. Deviation 107,58068 Minimum 51,40 Maximum 420,00 Range 368,60 Interquartile Range 148,85 Skewness -,246 ,564 Kurtosis -,597 1,091 PE Berat Mean 223,7782 12,58424

95% Confidence Interval for Mean Lower Bound 198,5588 Upper Bound 248,9976 5% Trimmed Mean 226,3623 Median 246,9500 Variance 8868,336 Std. Deviation 94,17185 Minimum 8,90 Maximum 387,80 Range 378,90 Interquartile Range 111,08 Skewness -,432 ,319 Kurtosis -,354 ,628 PE Ringan Mean 248,5615 19,39924

95% Confidence Interval for Mean Lower Bound 206,2942 Upper Bound 290,8288 5% Trimmed Mean 247,2350 Median 233,1000 Variance 4892,294 Std. Deviation 69,94494 Minimum 148,00 Maximum 373,00 Range 225,00 Interquartile Range 113,10 Skewness ,408 ,616 Kurtosis -,779 1,191

(31)

Kontrol

Mean 254,1165 6,72605

95% Confidence Interval for Mean Lower Bound 240,7410 Upper Bound 267,4920 5% Trimmed Mean 252,0399 Median 250,0000 Variance 3845,380 Std. Deviation 62,01113 Minimum 133,30 Maximum 458,80 Range 325,50 Interquartile Range 94,00 Skewness ,596 ,261 Kurtosis ,341 ,517

Tes Normalitas Data

Kolmogorov-Smirnova Shapiro-Wilk Statistic df Sig. Statistic df Sig. Eritrosit ,076 170 ,018 ,962 170 ,000 Hemoglobin ,084 170 ,005 ,975 170 ,004 Hematokrit ,081 170 ,008 ,977 170 ,007 MCH ,117 170 ,000 ,943 170 ,000 MCV ,139 170 ,000 ,922 170 ,000 MCHC ,077 170 ,015 ,978 170 ,008 Leukosit ,129 170 ,000 ,909 170 ,000 Trombosit ,054 170 ,200* ,987 170 ,123 *. This is a lower bound of the true significance.

a. Lilliefors Significance Correction

Tes Normalitas Transformasi Data

Kolmogorov-Smirnova Shapiro-Wilk Statistic df Sig. Statistic df Sig. Hemoglobin ,116 170 ,000 ,934 170 ,000 Hematokrit ,113 170 ,000 ,942 170 ,000

MCH ,141 170 ,000 ,912 170 ,000

MCV ,160 170 ,000 ,900 170 ,000

Leukosit ,066 170 ,064 ,988 170 ,147 a. Lilliefors Significance Correction

(32)

Tes Homogenitas Varian Data

Levene Statistic df1 df2 Sig. Eritrosit ,899 3 166 ,443 Hemoglobin ,018 3 166 ,997 Hematokrit ,086 3 166 ,968 MCH 1,543 3 166 ,205 MCV 2,205 3 166 ,089 MCHC 1,140 3 166 ,334 Leukosit 9,779 3 166 ,000 Trombosit 5,316 3 166 ,002

Tes Homogenitas Varian Transformasi Data

Levene Statistic df1 df2 Sig.

Leukosit ,952 3 166 ,417

Trombosit 7,894 3 166 ,000

Uji One Way ANOVA

Sum of Squares Df Mean Square F Sig.

Eritrosit Between Groups 6,501 3 2,167 8,201 ,000 Within Groups 43,860 166 ,264 Total 50,361 169 MCHC Between Groups 6,455 3 2,152 1,296 ,278 Within Groups 275,634 166 1,660 Total 282,089 169 Leukosit Between Groups 885,268 3 295,089 18,833 ,000 Within Groups 2601,045 166 15,669 Total 3486,313 169

(33)

Kruskal-Wallis Test

Ranks

Jenis_perlakuan N Mean Rank

Hemoglobin Eklampsia 16 108,84 PE Berat 56 100,96 PE Ringan 13 55,96 Kontrol 85 75,44 Total 170 Hematokrit Eklampsia 16 113,63 PE Berat 56 103,24 PE Ringan 13 57,54 Kontrol 85 72,79 Total 170 MCH Eklampsia 16 80,09 PE Berat 56 82,76 PE Ringan 13 83,85 Kontrol 85 88,58 Total 170 MCV Eklampsia 16 88,28 PE Berat 56 81,28 PE Ringan 13 96,54 Kontrol 85 86,07 Total 170 Trombosit Eklampsia 16 90,16 PE Berat 56 76,98 PE Ringan 13 85,00 Kontrol 85 90,31 Total 170

Test Statisticsa,b

Hemoglobin Hematokrit MCH MCV Trombosit Chi-Square 17,362 22,365 ,714 1,129 2,634

df 3 3 3 3 3

Asymp. Sig. ,001 ,000 ,870 ,770 ,452 a. Kruskal Wallis Test

(34)

Post Hoc Tests

Multiple Comparisons LSD Dependent Variable (I) Jenis_perlak uan (J) Jenis_perla kuan Mean Difference (I-J)

Std. Error Sig. 95% Confidence Interval Lower Bound Upper Bound

Eritrosit Eklampsia PE Berat -,09727 ,14571 ,505 -,3850 ,1904 PE Ringan ,49079* ,19193 ,011 ,1118 ,8697 Kontrol ,26993 ,14008 ,056 -,0066 ,5465 PE Berat Eklampsia ,09727 ,14571 ,505 -,1904 ,3850 PE Ringan ,58806* ,15825 ,000 ,2756 ,9005 Kontrol ,36720* ,08847 ,000 ,1925 ,5419 PE Ringan Eklampsia -,49079* ,19193 ,011 -,8697 -,1118 PE Berat -,58806* ,15825 ,000 -,9005 -,2756 Kontrol -,22086 ,15308 ,151 -,5231 ,0814 Kontrol Eklampsia -,26993 ,14008 ,056 -,5465 ,0066 PE Berat -,36720* ,08847 ,000 -,5419 -,1925 PE Ringan ,22086 ,15308 ,151 -,0814 ,5231 Hemoglobin Eklampsia PE Berat -,11089 ,48298 ,819 -1,0645 ,8427 PE Ringan 1,54385* ,63618 ,016 ,2878 2,7999 Kontrol ,83635 ,46431 ,073 -,0804 1,7531 PE Berat Eklampsia ,11089 ,48298 ,819 -,8427 1,0645 PE Ringan 1,65474* ,52453 ,002 ,6191 2,6904 Kontrol ,94725* ,29324 ,001 ,3683 1,5262 PE Ringan Eklampsia -1,54385* ,63618 ,016 -2,7999 -,2878 PE Berat -1,65474* ,52453 ,002 -2,6904 -,6191 Kontrol -,70749 ,50740 ,165 -1,7093 ,2943 Kontrol Eklampsia -,83635 ,46431 ,073 -1,7531 ,0804 PE Berat -,94725* ,29324 ,001 -1,5262 -,3683 PE Ringan ,70749 ,50740 ,165 -,2943 1,7093

(35)

Hematokrit Eklampsia PE Berat -,34857 1,30984 ,790 -2,9347 2,2375 PE Ringan 4,25644* 1,72534 ,015 ,8500 7,6629 Kontrol 2,71746* 1,25921 ,032 ,2313 5,2036 PE Berat Eklampsia ,34857 1,30984 ,790 -2,2375 2,9347 PE Ringan 4,60501* 1,42254 ,001 1,7964 7,4136 Kontrol 3,06603* ,79527 ,000 1,4959 4,6362 PE Ringan Eklampsia -4,25644* 1,72534 ,015 -7,6629 -,8500 PE Berat -4,60501* 1,42254 ,001 -7,4136 -1,7964 Kontrol -1,53899 1,37606 ,265 -4,2558 1,1779 Kontrol Eklampsia -2,71746* 1,25921 ,032 -5,2036 -,2313 PE Berat -3,06603* ,79527 ,000 -4,6362 -1,4959 PE Ringan 1,53899 1,37606 ,265 -1,1779 4,2558 MCH Eklampsia PE Berat ,01125 ,95774 ,991 -1,8797 1,9022 PE Ringan -,12058 1,26154 ,924 -2,6113 2,3702 Kontrol -,17526 ,92071 ,849 -1,9931 1,6426 PE Berat Eklampsia -,01125 ,95774 ,991 -1,9022 1,8797 PE Ringan -,13183 1,04014 ,899 -2,1854 1,9218 Kontrol -,18651 ,58149 ,749 -1,3346 ,9615 PE Ringan Eklampsia ,12058 1,26154 ,924 -2,3702 2,6113 PE Berat ,13183 1,04014 ,899 -1,9218 2,1854 Kontrol -,05469 1,00616 ,957 -2,0412 1,9318 Kontrol Eklampsia ,17526 ,92071 ,849 -1,6426 1,9931 PE Berat ,18651 ,58149 ,749 -,9615 1,3346 PE Ringan ,05469 1,00616 ,957 -1,9318 2,0412 MCV Eklampsia PE Berat ,69232 2,39927 ,773 -4,0447 5,4293 PE Ringan -,84981 3,16034 ,788 -7,0895 5,3898 Kontrol ,64474 2,30652 ,780 -3,9092 5,1986 PE Berat Eklampsia -,69232 2,39927 ,773 -5,4293 4,0447 PE Ringan -1,54213 2,60571 ,555 -6,6867 3,6025 Kontrol -,04759 1,45671 ,974 -2,9237 2,8285 PE Ringan Eklampsia ,84981 3,16034 ,788 -5,3898 7,0895 PE Berat 1,54213 2,60571 ,555 -3,6025 6,6867 Kontrol 1,49454 2,52057 ,554 -3,4820 6,4710

(36)

Kontrol Eklampsia -,64474 2,30652 ,780 -5,1986 3,9092 PE Berat ,04759 1,45671 ,974 -2,8285 2,9237 PE Ringan -1,49454 2,52057 ,554 -6,4710 3,4820 MCHC Eklampsia PE Berat -,15839 ,36528 ,665 -,8796 ,5628 PE Ringan ,09625 ,48115 ,842 -,8537 1,0462 Kontrol -,45304 ,35116 ,199 -1,1464 ,2403 PE Berat Eklampsia ,15839 ,36528 ,665 -,5628 ,8796 PE Ringan ,25464 ,39671 ,522 -,5286 1,0379 Kontrol -,29465 ,22178 ,186 -,7325 ,1432 PE Ringan Eklampsia -,09625 ,48115 ,842 -1,0462 ,8537 PE Berat -,25464 ,39671 ,522 -1,0379 ,5286 Kontrol -,54929 ,38375 ,154 -1,3069 ,2084 Kontrol Eklampsia ,45304 ,35116 ,199 -,2403 1,1464 PE Berat ,29465 ,22178 ,186 -,1432 ,7325 PE Ringan ,54929 ,38375 ,154 -,2084 1,3069 Leukosit Eklampsia PE Berat 5,78688* 1,12210 ,000 3,5714 8,0023 PE Ringan 6,92563* 1,47804 ,000 4,0074 9,8438 Kontrol 7,95410* 1,07873 ,000 5,8243 10,0839 PE Berat Eklampsia -5,78688* 1,12210 ,000 -8,0023 -3,5714 PE Ringan 1,13875 1,21865 ,351 -1,2673 3,5448 Kontrol 2,16722* ,68128 ,002 ,8221 3,5123 PE Ringan Eklampsia -6,92563* 1,47804 ,000 -9,8438 -4,0074 PE Berat -1,13875 1,21865 ,351 -3,5448 1,2673 Kontrol 1,02847 1,17883 ,384 -1,2990 3,3559 Kontrol Eklampsia -7,95410* 1,07873 ,000 -10,0839 -5,8243 PE Berat -2,16722* ,68128 ,002 -3,5123 -,8221 PE Ringan -1,02847 1,17883 ,384 -3,3559 1,2990 Trombosit Eklampsia PE Berat 23,55304 22,47074 ,296 -20,8122 67,9183 PE Ringan -1,23029 29,59869 ,967 -59,6687 57,2081 Kontrol -6,78522 21,60212 ,754 -49,4355 35,8651 PE Berat Eklampsia -23,55304 22,47074 ,296 -67,9183 20,8122 PE Ringan -24,78332 24,40417 ,311 -72,9659 23,3992

(37)

Kontrol -30,33826* 13,64304 ,028 -57,2745 -3,4020 PE Ringan Eklampsia 1,23029 29,59869 ,967 -57,2081 59,6687 PE Berat 24,78332 24,40417 ,311 -23,3992 72,9659 Kontrol -5,55493 23,60680 ,814 -52,1632 41,0533 Kontrol Eklampsia 6,78522 21,60212 ,754 -35,8651 49,4355 PE Berat 30,33826* 13,64304 ,028 3,4020 57,2745 PE Ringan 5,55493 23,60680 ,814 -41,0533 52,1632 *. The mean difference is significant at the 0.05 level.

Deskripsi Hemogbin dan Berat Bayi Lahir

Statistic Std. Error

Hemoglobin

Mean 1,0684 ,00536

95% Confidence Interval for Mean Lower Bound 1,0578 Upper Bound 1,0790 5% Trimmed Mean 1,0725 Median 1,0810 Variance ,005 Std. Deviation ,06995 Minimum ,80 Maximum 1,23 Range ,43 Interquartile Range ,08 Skewness -1,071 ,186 Kurtosis 1,656 ,370 BBL Mean 3,4224 ,01175

95% Confidence Interval for Mean

Lower Bound 3,3992 Upper Bound 3,4456

5% Trimmed Mean 3,4390

(38)

Variance ,023 Std. Deviation ,15320 Minimum 2,54 Maximum 3,66 Range 1,12 Interquartile Range ,13 Skewness -2,353 ,186 Kurtosis 8,192 ,370

Tes Normalitas Hemogbin dan Berat Bayi Lahir

Kolmogorov-Smirnova Shapiro-Wilk Statistic Df Sig. Statistic df Sig. Hemoglobin ,084 170 ,005 ,975 170 ,004

BBL ,118 170 ,000 ,961 170 ,000

a. Lilliefors Significance Correction

Tes Normalitas Transformasi Hemogbin dan Berat Bayi Lahir

Kolmogorov-Smirnova Shapiro-Wilk Statistic df Sig. Statistic df Sig.

Hemoglobin ,116 170 ,000 ,934 170 ,000

BBL ,170 170 ,000 ,799 170 ,000

a. Lilliefors Significance Correction

Uji Korelas Spearman

Hemoglobin BBL Hemoglobin Pearson Correlation 1 -,269** Sig. (2-tailed) ,000 N 170 170 BBL Pearson Correlation -,269** 1 Sig. (2-tailed) ,000 N 170 170

(39)
(40)

Lampiran 4. Biodata Mahasiswa

Identitas

Nama

: Candra Cahyaningtyas Giyanto

NIM

: 22010111130090

Tempat/ tanggal lahir : Pekalongan, 28 Agustus 1993

Jenis kelamin

: Perempuan

Alamat

: JalanLPPU II No. 11 Tembalang, RT 02/RW 04,

Semarang

Nomor HP

: 085866239993

E-mail

: CandraGiyanto@gmail.com

Riwayat Pendidikan Formal

1.

SD

: SD Negeri Doro 01

Lulus tahun : 2005

2.

SMP

: SMP Negeri 2 Pekalongan

Lulus tahun : 2008

3.

SMA

: SMA Negeri 1 Pekalongan Lulus tahun : 2011

4.

FK UNDIP

: Masuk tahun : 2011

Keanggotaan Organisasi

1.

Anggota RHEU tahun 2014

2.

Asisten Parasitologi tahun 2014

Pengalaman Penelitian -

Pengalaman Publikasi Tulisan Ilmiah -

Pengalaman Presentasi Karya Tulis -

Referensi

Dokumen terkait

Tujuan yang hendak dicapai dalam pengamatan ini adalah : 1. Untuk mengetahui siapa saja target pasar Dagadu Djokdja. Untuk mengetahui strategi promosi yang diterapkan pada

International Nickel Indonesia, Tbk dilihat dari analisis keuangan dilihat dari rasio profitabilitas dikatakan memiliki kinerja yang baik dimana, pihak manajemen

Nuriyyah Ma‟shoem sebagai ulama perempuan dalam pendidikan dibuktikan dengan kontribusinya dalam kehidupan sosial karena dalam diri beliau terdapat ciri keulamaan berupa

Bersama dengan sudut geser dalam, kohesi merupakan parameter kuat geser tanah yang menentukan ketahanan tanah terhadap deformasi akibat tegangan yang bekerja pada tanah dalam hal

perusahaan dibandingkan dengan penjualan dalam suatu periode tertentu.. 2) Untuk menghitung lamanya rata-rata penagihan piutang usaha, serta sebaliknya untuk

Dalam upaya meningkatkan mutu dan produktivitas hasil pertanian, penggunaan pestisida untuk membasmi hama tanaman sering tidak dihindarkan (Djojosumarto, 2000). Pengendalian

Dari uraian latar belakang tersebut, maka rumusan masalah yang diangkat yaitu (a) Akses masuk bagi para pengunjung yang masih belum terarah, adanya wisatawan yang dapat

Zihaf: perubahan yang terjadi pada huruf kedua dari sabab, baik sabab tsaqil dengan mematikan huruf hidup, atau sabab Khafif dengan membuang huruf mati.. Huruf